1. Metabolic syndrome in Spanish patients with psoriasis needing systemic therapy: Prevalence and association with cardiovascular disease in PSO-RISK, a cross-sectional study. (August 2015) Authors: Belinchón, I.; Vanaclocha, F.; de la Cueva-Dobao, P.; Coto-Segura, P.; Labandeira, J.; Herranz, P.; Taberner, R.; Juliá, B.; Cea-Calvo, L.; Puig, L. Journal: Journal of dermatological treatment Issue: Volume 26:Number 4(2015:Aug.) Page Start: 318 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Safety and effectiveness of ustekinumab and antitumour necrosis factor therapy in patients with psoriasis and chronic viral hepatitis B or C: a retrospective, multicentre study in a clinical setting. (28th February 2013) Authors: Navarro, R.; Vilarrasa, E.; Herranz, P.; Puig, L.; Bordas, X.; Carrascosa, J.M.; Taberner, R.; Ferrán, M.; García‐Bustinduy, M.; Romero‐Maté, A.; Pedragosa, R.; García‐Diez, A.; Daudén, E. Journal: British journal of dermatology Issue: Volume 168:Number 3(2013:Mar.) Page Start: 609 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗